Protein Interactions (protein-protein, protein-DNA/RNA, protein-cell), Protein Interaction Modulation (e.g. drug screening), “Toxic” Oligomer Characterization and Interactions (amyloid beta, alpha synuclein: self and hetero interactions with apoE isoforms and tau), Network-Based Biomarker and Drug Discovery, Complement System, Functional Proteomics, Proteolysis